1 / 7

EpiCast Report: Insomnia Epidemiology Market Size to 2023

Big Market Research EpiCast Report: Insomnia Epidemiology Market Size, Share, Global Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation, Forecast, 2023. Get full report & TOC here @ http://www.bigmarketresearch.com/epicast-report-insomnia-epidemiology-forecast-to-2023-market GlobalData epidemiologists forecast that the total prevalent cases of acute insomnia in the 7MM will increase from 121,799,911 total prevalent cases in 2013, to 130,482,156 total prevalent cases in 2023 at an Annual Growth Rate (AGR) of 0.71%. GlobalData epidemiologists forecast an increase in the total prevalent cases of chronic insomnia (not fulfilling DSM-IV criteria) in the 7MM from 62,982,390 total prevalent cases in 2013, to 67,471,957 total prevalent cases in 2023 at an AGR of 0.71%.

Download Presentation

EpiCast Report: Insomnia Epidemiology Market Size to 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. EpiCast Report: Insomnia - Epidemiology Forecast to 2023 www.bigmarketresearch.com

  2. Acquired (Autoimmune) Hemolytic Anemia Report Description GlobalData epidemiologists forecast that the total prevalent cases of acute insomnia in the 7MM will increase from 121,799,911 total prevalent cases in 2013, to 130,482,156 total prevalent cases in 2023 at an Annual Growth Rate (AGR) of 0.71%. GlobalData epidemiologists forecast an increase in the total prevalent cases of chronic insomnia (not fulfilling DSM-IV criteria) in the 7MM from 62,982,390 total prevalent cases in 2013, to 67,471,957 total prevalent cases in 2023 at an AGR of 0.71%. The 7MM had an estimated 23,690,040 total prevalent cases of chronic primary insomnia in 2013 and the number of total prevalent cases is expected to increase to 25,378,728 by 2023, at an AGR of 0.71%. GlobalData epidemiologists forecast that the total prevalent cases of chronic secondary insomnia in the 7MM will increase from 53,697,425 total prevalent cases in 2013, to 57,525,122 total prevalent cases in 2023 at an AGR of 0.71%. Read complete report here @ http://www.bigmarketresearch.com/epicast-report-insomnia-epidemiology-forecast-to-2023-market

  3. Acquired (Autoimmune) Hemolytic Anemia Report Description Insomnia is a highly prevalent condition; approximately one third of the general population presents with some degree of insomnia. GlobalData epidemiologists used comprehensive country-specific data from population-based studies published in peer-reviewed journal articles to arrive at a meaningful, in-depth analysis and forecast for the total prevalent cases of acute insomnia, chronic insomnia (not fulfilling DSM-IV criteria), chronic primary insomnia, and chronic secondary insomnia in the 7MM, based on the DSM-IV criteria. For all the 7MM, the total prevalent cases of acute insomnia, chronic insomnia (not fulfilling DSM-IV criteria), chronic primary insomnia, and chronic secondary insomnia were segmented by age and sex, which facilitates an understanding of the distribution of the disease within the population and informs strategies to improve the management of the disease. Furthermore, the forecast methodology is consistent across each of the 7MM, thereby allowing for a meaningful comparison of the forecast total prevalent cases among each market. Get enquire about report here @ http://www.bigmarketresearch.com/report-enquiry/178077

  4. Acquired (Autoimmune) Hemolytic Anemia Table Of Contents • 1. Introduction • Catalyst • Related Reports • Upcoming Related Reports • 2. Europe Refining Industry • Disease Background • Risk Factors and Comorbidities • Global Trends • Forecast Methodology • Sources Used • Sources Not Used • Forecast Assumptions and Methods • Epidemiological Forecast for Acute Insomnia (2013-2023)

  5. Acquired (Autoimmune) Hemolytic Anemia Table Of Contents • 3. Appendix • Bibliography • About the Authors • Epidemiologists • Reviewers • Global Director of Therapy Analysis and Epidemiology • Get complete TOC @http://www.bigmarketresearch.com/epicast-report-insomnia-epidemiology-forecast-to-2023-market

  6. Acquired (Autoimmune) Hemolytic Anemia Report Description • Reasons to buy • Develop business strategies by understanding the trends shaping and driving the global insomnia market. • Quantify patient populations in the global insomnia market to improve product design, pricing, and launch plans. • Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for insomnia therapeutics in each of the markets covered.

  7. FOR MORE DETAILS Visit us at : http://www.bigmarketresearch.com/epicast-report-insomnia-epidemiology-forecast-to-2023-market Stay With Us: 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States • TELEPHONE: +1 (855) 711-1555E-MAIL: help@bigmarketresearch.com

More Related